Drugs · acquisition-cost intelligence
Calcipotriene and Betamethasone Dipropionate
· ingredient betamethasoneCorticosteroids· BETAMETHASONE DIPROPIONATE .5 mg/g; CALCIPOTRIENE MONOHYDRATE 50 ug/g; BETAMETHASONE DIPROPIONATE .643 mg/g; CALCIPOTRIENE 50 ug/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$2.07
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other betamethasone products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Betamethasone Dipropionate | $0.16833 | −$1.91 |
| Clobezin | $0.19868 | −$1.88 |
| Betamethasone Dipropionate | $0.30015 | −$1.77 |
| betamethasone dipropionate | $0.41588 | −$1.66 |
| Betamethasone dipropionate | $0.45908 | −$1.62 |
| Betamethasone Dipropionate | $0.53787 | −$1.54 |
| betamethasone valerate | $0.57225 | −$1.50 |
| DIPROLENE | $0.61496 | −$1.46 |
Medicare Part D coverage · CY2026
On 14 plan formularies · typical tier 4
Prior auth 21% · Step therapy 7% · Quantity limit 29% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.